Sam Samad insider trades

Open-market stock purchases and sales by Sam Samad, Executive Vice President & CFO at Quest Diagnostics Inc, from SEC Form 4 filings since Sep 1, 2019.

Recent trades

DateStockTradeValue
Jul 22, 2026DGX Quest Diagnostics IncBought (not open market)$21.1K
May 12, 2026IDXX Idexx Laboratories Inc /DEBought (not open market)—
May 12, 2026IDXX Idexx Laboratories Inc /DEBought (not open market)—
Apr 20, 2026DGX Quest Diagnostics IncBought (not open market)$21K
Mar 4, 2026DGX Quest Diagnostics IncBought (not open market)$2.9M
Mar 4, 2026DGX Quest Diagnostics IncSold (not open market)$1.6M
Mar 2, 2026DGX Quest Diagnostics IncSold (not open market)$178K
Feb 18, 2026DGX Quest Diagnostics IncBought (not open market)—
Feb 18, 2026DGX Quest Diagnostics IncBought (not open market)—
Feb 18, 2026DGX Quest Diagnostics IncSold (not open market)$180K
Feb 18, 2026DGX Quest Diagnostics IncSold (not open market)$209K
Jan 28, 2026DGX Quest Diagnostics IncBought (not open market)$12.7K
Oct 21, 2025DGX Quest Diagnostics IncBought (not open market)$12.9K

Companies traded

  • DGX Quest Diagnostics Inc: other filings, last Jul 22, 2026
  • IDXX Idexx Laboratories Inc /DE: other filings, last May 12, 2026
  • ILMN Illumina, Inc: 7 sales, last Mar 1, 2022

Get free alerts when Sam Samad files a new trade →